BRCA1/2 tumor NGS analyses were performed for 502 patients (50.3%), and a total of 62 TPVs were detected (12.4% of all NGS analyses); 31 TPVs in BRCA1 and 31 TPVs in BRCA2 (Table 2). The gene discussed is BRCA2; the disease is neoplasm.